Edition:
United States

Akorn Inc (AKRX.OQ)

AKRX.OQ on NASDAQ Stock Exchange Global Select Market

21.22USD
30 Nov 2016
Change (% chg)

-- (--)
Prev Close
$21.22
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
414,143
52-wk High
$39.46
52-wk Low
$17.58

AKRX.OQ

Chart for AKRX.OQ

About

Akorn Inc., together with its subsidiaries, is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments:... (more)

Overall

Beta: 1.14
Market Cap(Mil.): $2,729.00
Shares Outstanding(Mil.): 125.24
Dividend: --
Yield (%): --

Financials

  AKRX.OQ Industry Sector
P/E (TTM): 14.65 29.13 29.87
EPS (TTM): 1.49 -- --
ROI: 10.06 15.56 14.95
ROE: 26.47 16.69 16.29

BRIEF-Akorn invalidates Durezol patent via inter partes review proceeding

* On November 22, 2016, patent trial and appeal board ruled in favor of Akorn in its inter partes review proceeding

Nov 28 2016

BRIEF-Akorn Q3 earnings per share $0.38

* Now sees 2016 net revenue $ 1.125 billion from $1.06-$1.08 billion earlier

Nov 03 2016

BRIEF-Akorn relaunches Ofloxacin Otic solution

* Akorn relaunches Ofloxacin Otic solution Source text for Eikon: Further company coverage:

Aug 25 2016

BRIEF-Akorn reported Q2 EPS $0.50

* Q2 adjusted NON-GAAP earnings per share $0.58 including items

Aug 04 2016

Earnings vs. Estimates